When fractures outnumber eligibility criteria: a case-based reflection on access to osteoanabolic therapy
Authors:
- Hilmi Berkan AbacıoğluHAHilmi Berkan Abacıoğlu
- Hilmi BerkanHBHilmi Berkan
- Ahmet Furkan ÇolakAÇAhmet Furkan Çolak
- Berkay YalçınkayaBYBerkay Yalçınkaya
- Alp ÇetinAÇAlp Çetin
- 23 October 2026
- journal article
- letter
- Published by Springer Nature in Osteoporosis International
- p. 1-3
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Romosozumab versus teriparatide and risk of all-cause mortality in patients with osteoporosis: a real-world propensity score-matched cohort studyOsteoporosis International, 2026
- Recommendations for the optimal use of bone forming agents in osteoporosisAging Clinical and Experimental Research, 2024
- Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003–2021JBMR Plus, 2023
- Algorithm for the management of patients at low, high and very high risk of osteoporotic fracturesOsteoporosis International, 2019